Progressive Brain Iron Accumulation in Neuroferritinopathy Measured by the Thalamic T2* Relaxation Rate

References

1. 1.↵
   1. Curtis AJ,
   2. Fey C,
   3. Morris CM,
   4. et al

   . Mutation in the gene encoding ferritin light chain polypeptide causes adult onset autosomal dominant basal ganglia disease. Nat Genet 2001; 28: 350– 54

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Chinnery PF,
   2. Crompton DE,
   3. Birchall D,
   4. et al

   . Clinical features and natural history of neuroferritinopathy caused by the FTL1 460insA mutation. Brain 2007; 130: 110– 19

   Abstract/FREE Full Text
3. 3.↵
   1. Mancuso M,
   2. Davidzon G,
   3. Kurlan RM,
   4. et al

   . Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights. J Neuropathol Exp Neurol 2005; 64: 280– 94

   PubMedWeb of Science
4. 4.↵
   1. Vidal R,
   2. Ghetti B,
   3. Takao M,
   4. et al

   . Intracellular ferritin accumulation in neuronal and extra-neuronal tissues characterises a neurodegenerative disorder associated with a mutation in the ferritin light polypeptide gene. J Neuropath Exp Neurol 2004; 63: 363– 80

   PubMedWeb of Science
5. 5.↵
   1. McNeill A,
   2. Birchall D,
   3. Hayflick SY,
   4. et al

   . T2* and FSE MRI distinguish four subtypes of neurodegeneration with brain iron accumulation. Neurology 2008; 70: 1614– 19

   Abstract/FREE Full Text
6. 6.↵
   1. House MJ,
   2. St Pierre TG,
   3. Kowdley KV,
   4. et al

   . Correlation of proton transverse relaxation rates (R2) with iron concentrations in postmortem brain tissue from Alzheimer's disease patients. Magn Reson Med 2007; 57: 172– 80

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Gelman N,
   2. Gorell JM,
   3. Barker PB,
   4. et al

   . MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology 1999; 210: 759– 67

   PubMedWeb of Science
8. 8.↵
   1. Jensen JH,
   2. Szulc K,
   3. Hu C,
   4. et al

   . Magnetic field correlation as a measure of iron-generated magnetic field inhomogeneities in the brain. Magn Reson Med 2009; 61: 481– 85

   CrossRefPubMed
9. 9.↵
   1. Ordidge RJ,
   2. Gorell JM,
   3. Deniau JC,
   4. et al

   . Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla. Magn Reson Med 1994; 32: 335– 41

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Aquino D,
    2. Bizzi A,
    3. Grisoli M,
    4. et al

    . Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects. Radiology 2009; 1: 165– 72
11. 11.↵
    1. Szumowski J,
    2. Bas E,
    3. Gaarder K,
    4. et al

    . Measurement of brain iron distribution in Hallevorden-Spatz syndrome. J Magn Reson Imaging 2010; 31: 482– 89

    CrossRefPubMed
12. 12.↵
    1. Mittal S,
    2. Wu Z,
    3. Neelavalli J,
    4. et al

    . Susceptibility-weighted imaging: technical aspects and clinical applications. AJNR Am J Neuroradiol 2009; 30: 232– 52

    Abstract/FREE Full Text